Iovance Biotherapeutics: Cell Therapy Solutions from Trusted Suppliers

We are excited to announce a collaborative partnership between Iovance Biotherapeutics and T&L Biotechnology Co., Ltd. to bring innovative cell therapies to patients in need. Our joint mission is to develop and commercialize novel cancer immunotherapies using TIL (tumor-infiltrating lymphocyte) technology, Iovance Biotherapeutics is a leader in the field of TIL therapy, harnessing the power of a patient's own immune system to target and destroy cancer cells. With a strong track record of clinical success, Iovance is at the forefront of developing personalized cancer treatments, T&L Biotechnology Co., Ltd. has a proven expertise in Cell Therapy manufacturing and a deep commitment to advancing biotechnology for the benefit of patients. By joining forces with Iovance, we aim to accelerate the development and commercialization of TIL therapies to improve the lives of cancer patients, Together, we are dedicated to pushing the boundaries of what is possible in cancer treatment, and we look forward to bringing our innovative TIL therapies to patients around the world